Brain MRI and clinical exam findings in women with multiple gadolinium-based contrast agent (GBCA) exposures due to screening breast MRIs

Multiple exposures to gadolinium-based contrast agents (GBCAs) is known to be associated with gadolinium deposition in the brain in certain patients. Such deposition has been correlated with specific brain MRI findings, although most available data is in patients with underlying neurologic disorders. We aim to prospectively evaluate brain MRI signal changes as well as neurologic and neuropsychologic testing results in women undergoing screening breast MRI.

Source: Clinical Imaging - September 29, 2022 Category: Radiology Authors: Kelly S. Myers, David M. Yousem, Kelly A. Mills, Khaled Gad, Sanaz Ghaderi Niri, Nicholas Bienko, Cynthia A. Munro Tags: Neuroradiology Source Type: research